Oncotartis, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma (NCT03921879) | Oncotartis, Inc. | 2019-07-29 |
Track Oncotartis, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.